HCA Healthcare, Inc. (NYSE:HCA) Declares Quarterly Dividend of $0.66

HCA Healthcare, Inc. (NYSE:HCA) declared a quarterly dividend on Tuesday, July 23rd, Zacks reports. Investors of record on Monday, September 16th will be paid a dividend of 0.66 per share on Monday, September 30th. This represents a $2.64 annualized dividend and a yield of 0.67%. The ex-dividend date is Monday, September 16th.

HCA Healthcare has raised its dividend payment by an average of 77.4% per year over the last three years. HCA Healthcare has a dividend payout ratio of 10.6% meaning its dividend is sufficiently covered by earnings. Research analysts expect HCA Healthcare to earn $24.89 per share next year, which means the company should continue to be able to cover its $2.64 annual dividend with an expected future payout ratio of 10.6%.

HCA Healthcare Stock Performance

HCA opened at $394.68 on Friday. The firm has a 50 day moving average of $362.19 and a two-hundred day moving average of $338.06. The firm has a market capitalization of $101.86 billion, a PE ratio of 19.67, a P/E/G ratio of 1.46 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. HCA Healthcare has a 12-month low of $215.96 and a 12-month high of $403.05.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period last year, the firm earned $4.29 EPS. On average, analysts anticipate that HCA Healthcare will post 22.46 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Wells Fargo & Company upped their price target on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. Robert W. Baird assumed coverage on HCA Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective for the company. Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Monday, August 19th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $359.89.

Insider Activity

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.